Forum LABO Paris 2027

Capture More: Improving Sensitivity and Accuracy in cfDNA Sequencing

Description

Capture More: Improving Sensitivity and Accuracy in cfDNA Sequencing Liquid biopsy offers a minimally invasive way to investigate disease-associated changes through circulating cell-free DNA (cfDNA), with applications in cancer detection, tissue-of-origin analysis and disease monitoring. However, cfDNA is scarce, highly fragmented and heterogeneous, making efficient recovery and reliable library preparation essential for sensitive and accurate analysis. This presentation focuses on an integrated workflow addressing two key challenges. - First, special magnetic-bead extraction chemistry enables recovery of a broad cfDNA size range. This includes very short fragments that are often missed by conventional extraction methods, although they can contain important information. - Second, a native-end-preserving library preparation strategy based on Splinted Ligation Adapter Tagging (SPLAT) enables direct adapter ligation without end repair. By avoiding enzymatic modification of DNA ends, this approach helps preserve native fragment termini, reduce processing-related biases and retain valuable information from short, nicked or damaged molecules. For epigenetic studies, the workflow can be complemented by whole-genome bisulfite sequencing (WGBS), enabling genome-wide DNA methylation profiling from low-input cfDNA. Together, these approaches provide access to complementary layers of information beyond genetic alterations, including fragment lengths, native DNA ends and methylation patterns. Combining these insights may support more sensitive and informative approaches to early cancer detection, tissue-of-origin analysis and disease monitoring. Key Takeaways • Recover more: Capture a broader range of cfDNA fragment sizes, including very short fragments. • Preserve more: Avoid end repair to retain native DNA ends and minimize processing-related biases • Discover more: Combine genetic, epigenetic and fragmentomic insights through complementary sequencing approaches.

Speakers

In partnership with

Suggested sessions

Agora
Mar 23, 2027
10:00 AM11:30 AM
Innovation and scientific valorization

Opening conference - The laboratory in motion: how can we improve efficiency, strengthen reliability, and advance sustainable practices?

Description
Tight budgets, regulatory requirements, automation and artificial intelligence, resource optimization, environmental and climate imperatives... Laboratories must reconcile growing challenges while supporting their teams and preparing for the transformations of the coming years. • How can they innovate while keeping costs under control? • How can they automate while retaining control over operations? • How can they strengthen the reliability of results and reduce their environmental footprint with a constant budget? • How can they develop and retain the necessary skills without increasing pressure on teams? • Though these demands may seem contradictory, they can become drivers of progress. Drawing on feedback from laboratories that have successfully carried out transformations, this opening conference explores the technological, organizational, and human choices that are proving effective. Artificial intelligence, precision or miniaturized instrumentation, new sustainable practices: what concrete benefits can they deliver, what conditions are needed for success, and what impact will they have on professions and roles? Looking at yesterday’s choices to shed light on today’s decisions: which strategic shifts have paid off, which practices can be adapted to other organizations, and which directions should be taken as early as 2027?
Agora
Mar 23, 2027
11:30 AM12:00 PM
Innovation and scientific valorization

Innovation Awards Ceremony

Description
The Forum LABO 2027 Awards celebrate and recognize projects, laboratories, teams, and individuals who stand out for their scientific or technical excellence, a major innovation, or a significant impact on their region, their sector, or the scientific community. These awards also encourage collaboration, equality, and diversity in the scientific world.
Salle Marie Curie
Mar 23, 2027
2:00 PM3:00 PM
Biotechnology, science and healthcare of tomorrow

Inside the Joint Laboratory Service

Description
The Joint Laboratory Service stands out for its unique way of operating, making it a network of official laboratories at the heart of government action. It works for several government bodies on an extremely wide range of issues, from toys to narcotics, from verifying the accuracy of claims to food safety, as well as checking geographical origins and the naturalness of ingredients. Its scope of expertise covers 29 scientific fields and includes handling samples collected by inspection authorities, both for high-volume routine analyses (for example, pesticide residues in imported fruit and vegetables) and for in-depth expert investigations on specific topics (for example, the structural elucidation of new psychoactive substances using NMR and high-resolution mass spectrometry).
Le Service Commun des Laboratoire
Atelier Exposant - Salle 2
Mar 23, 2027
2:00 PM3:00 PM
Transition & regulationIndustry & materialsInnovation and scientific valorization

La technologie TriMax des colonnes RMX améliore les performances de vos analyses GC

Speakers:
THIERRY LAURENTRESTEK FRANCEIngénieur technico commercial
Description
Laboratories today face increasingly demanding requirements: lower detection limits, more complex matrices, regulatory constraints, and a growing need for productivity. Discover how the new Restek RMX columns, featuring the revolutionary TriMax deactivation technology, help improve sensitivity, the quality of your results, and column lifetime for GC-MS and GC-MS/MS methods. Through concrete examples from environmental analyses involving compounds that are difficult to identify (SVOC, PAH, PCB), we will see how to obtain more reliable results while improving method robustness and extending column lifetime. Key takeaways: • Improved inertness of RMX columns thanks to TriMax technology → increased sensitivity for difficult compounds (SVOC, PAH, PCB) • Extended column lifetime → fewer replacements, less maintenance time • Greater robustness → lower detection limits, easier regulatory compliance
Restek France
Salle Marie Curie
Mar 23, 2027
3:00 PM3:45 PM
Biotechnology, science and healthcare of tomorrow

Hemarina – a human, scientific and entrepreneurial adventure

Description
Oxygen is essential to life, and hemoglobin is the molecule responsible for transporting almost all of the oxygen present in the circulatory system of most living species. During this conference, our speaker will retrace the story of the discovery of a natural extracellular hemoglobin called M101, derived from a marine organism, Arenicola marina, and its applications in medicine. This non-allergenic and non-immunogenic molecule carries 40 times more oxygen than HbA and is 250 times smaller than a red blood cell. Its intrinsic properties make it a broad-spectrum therapeutic tool for ensuring effective tissue oxygenation in various clinical situations where ischemia and/or anemia are the triggering factors. The applications of the M101 molecule are almost limitless, as it can potentially act wherever oxygen is needed: in composite tissue transplants (organs, skin, face, limbs, etc.), during vaso-occlusive crises in patients with sickle cell disease, in cases of myocardial infarction, cerebral ischemia, in oncology (radiotherapy, CAR-T cells for hypoxic tumors), in the development of oxygenating dressings for hypoxic wounds, and in the treatment of periodontal diseases. This presentation will provide an overview of the development of the M101 molecule and its various therapeutic applications.
HEMARINA
Agora
Mar 23, 2027
3:00 PM3:45 PM
Biotechnology, science and healthcare of tomorrow

SFSTP +POLEPHARMA

Description
Information coming soon